Contraindications CJC-1295 and Ipamorelin peptide therapy may not be suitable for individuals who: Have active or recent cancer Are pregnant or breastfeeding Are under the age of 18 Have uncontrolled blood sugar disorders A medical consultation is required to determine suitability prior to treatment
The MHRA's stated read is that there is little credible scientific evidence behind the claims, the products are unlicensed, and the marketing has run a long way ahead of the data
It boosts collagen, fades dark spots, and refines poresall with long-lasting results
"We don't really know why some people only lose 5% where some people are super responders and losing 30% of their body weight." Kushner thinks of the result as a kind of new settling point the medication helps establish, though why it lands so much lower for some people isn't well understood
LWW Journals , Tchang, Beverly G., et al